The U.S. Department of Justice and the FDA have taken steps to continue barring Actavis Totowa from manufacturing and distributing generic drugs. The actions were taken following a series of serious manufacturing problems which resulted in a nationwide Digitek recall earlier this year when double strength tablets were produced, and a subsequent recall that involved potential issues with over 65 different generic drugs. Continued
All Posts Tagged With: "digoxin"
Digitek Lawyers Appointed to Leadership Roles in Federal MDL
U.S. District Judge Joseph Goodwin, who is handling the consolidated Digitek lawsuits in West Virginia, has issued a pretrial order appointing Co-Lead Attorneys and members of the Plaintiffs’ Steering Committee in the MDL, or Multidistrict Litigation. These lawyers will perform services that benefit all of the plaintiffs during pretrial phase of the litigation. Continued
Digitek Litigation: Judge Appoints Lawyers as Plaintiffs’ Co-Liaison Counsel
U.S. District Judge Joseph R. Goodwin, who is overseeing the consolidated Digitek Litigation, appointed two lawyers to serve as Plaintiffs’ Co-Liaison Counsel in the federal MDL formed last month in the Sourthern District of West Virginia. Continued
Federal Digitek Lawsuits Consolidated in Southern District of West Virginia
The United States Judicial Panel on Multidistrict Litigation has ordered that all Digitek lawsuits filed as a result of allegedly defective and double strength digoxin tablets, be transferred to the Southern District of West Virginia for consolidation through pretrial litigation. Continued
Digitek Recall Lawsuits
On April 25, 2008, a nationwide Digitek Tablet Recall was issued for all lots of the heart medication. Manufacturing problems caused some tablets to contain twice as much of the active ingredient as is appropriate. This could result in digitalis toxicity in patients with impaired kidney function, which is a serious and potentially fatal illness. Continued
Actavis Recalls Over 65 Generic Drugs Made at NJ Plant
On August 1, 2008, Actavis Totowa, LLC announced the recall of over 65 different generic drugs the company manufactured at the same New Jersey plant where they previously produced defective Digitek tablets which were recalled in April 2008. The recall was extended to all medications made at the plant after an FDA investigation found that the drug maker was not following good manufacturing practices. Continued
Motion Filed to Consolidate West Virginia Digitek Lawsuits
Lawyers representing individuals who filed Digitek lawsuits in West Virginia state court alleging injuries caused by double strength digoxin tablets which were recalled earlier this year, have filed a motion to consolidate all of the lawsuits before one judge. According to the motion, lawyers estimate that there will likely be thousands of Digitek lawsuits filed in West Virginia state court. Continued
Digitek Lawsuits Filed in West Virginia as a Result of Double Strength Tablets
Two West Virginia lawsuits were filed last week as a result of injuries suffered by users who allegedly received Digitek pills that contained twice the approved level of active ingredient. On April 25, 2008, all lots of Digitek, also known as digoxin, were recalled due to a risk that double strength tablets may increase the risk of digitalis toxicity, caused by a build up of the drug in the body. Continued
Following Digitek Recall, Class Action Suits have been filed
At least two class action suits have been filed on behalf of individuals who used the heart drug Digitek (digoxin). The suits come less than three weeks after all lots of Digitek were recalled on April 25th when it was discovered that some tablets sold over the past year could be twice as thick as is appropriate and contain double the approved amount of active ingredient. Continued
